Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
23 April 2010
IN THIS ISSUE
Pharma growth for 2014
EMA evaluation
FDA environmental recall
SOCMA raises concerns
PTE on LinkedIn
 
Pharma to be worth $1 trillion by 2014
Despite pharma's upcoming peak years of patent expiries and the threat of generic competition, growth during the next 5 years is expected to be strong with the global market for pharmaceuticals forecast to reach more than $1 trillion by 2014, according to IMS Health. More...
 
European Medicines Agency praised in evaluation
An evaluation conducted by Ernst & Young assessing the effectiveness and efficiency of the European Medicines Agency has largely praised the agency; however, a number of strategic and operational recommendations for further improvements have also been made. More...
 
FDA removes last environmentally unfriendly products from the market
After several years of debate and review, the FDA is now calling for the removal of metered-dose inhalers that use ozone-depleting chlorofluorocarbons (CFCs) to propel the medication into a user’s lungs. More...
 
SOCMA raises concerns about Toxic-Substances Reform Bill
The Society of Chemical Manufacturers and Affiliates (SOCMA) has issued a statement raising concerns about the Safe Chemicals Act of 2010, a bill recently introduced in the US Senate that seeks to reform the Toxic Substances Control Act (TSCA). More...
 
Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...

Product Profile
Agilent
The Agilent 2100 Bioanalyzer plus the Agilent High Sensitivity Protein 250 Kit automatically detects and quantifies protein impurities down to 0.05% – efficient and in production-ready method!

Read more...

Product Profile
Centre for Professional Advancement
Access Training You Need Now

With over 100 Live and On-Demand Online Training courses, and nearly 300 instructor led courses to choose from - CfPA’s Accredited courses can ensure you receive the skills and knowledge that will make a difference in your career. Register now for: IQ/OQ/PQ Dublin 10 Feb, Root Cause Investigation for CAPA Dublin 24 Feb, or Effective FDA Submissions 12 Feb Online.

Read more...

Product Profile
Watson Marlow
New weldable pump tube

PureWeld XL from Watson-Marlow, a new weldable and ADCF (animal-derived contents free) tube for use in bio-pharmaceutical processes, provides users with secure joins that allow for a connector-free fluid path. PureWeld demonstrates very low internal spallation and gives long tube life in peristaltic pump applications.
Read more...

Event profile
9th Annual Biological Production Forum 2010
21st - 23rd June 2010
Sheraton Frankfurt Hotel & Towers, Frankfurt, Germany

9th Annual Biological Production Forum 2010 is the event focusing on both upstream and downstream processing for biological manufacturing, production and cGMP specialists. Over the course of this 3 day event, you will take part in a mixture of networking and conference session featuring the latest strategies and industry case studies.

Read more...

Key Topic Updates
Latest blog posts
Separate and unequal at Novartis?
Puerto Rico focuses on diversifying bio/pharmaceutical base
Patent expiries good news for healthcare providers
More blog posts

May events
BIO 2010 (3–6 May | USA)
EUPAT4 (5–6 May | Finland)
ExcipientFest Americas (5–6 May | Puerto Rico)
More events

PTE Digital
The personalized medicine marathon
The hype, hope and reality of pharmacogenetic tests
Progress in molecular diagnostics
View the issue

Key Topic Updates

Survey
How do you think the recently passed US healthcare reform law will affect the pharma and biopharma industries?
  Benefit the pharmaceutical and biotechnology industries. 38%
  Hurt the pharmaceutical and biotechnology industries. 32%
  Have no impact on the pharmaceutical and biotechnology industries. 5%
  Don’t know what the implications to the pharmaceutical and biotechnology industries will be. 25%

This week we would like to know...

For what reason is your manufacturing facility purchasing more equipment?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.


 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail

at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom